γ-Secretase Modulator (GSM) Photoaffinity Probes Reveal Distinct Allosteric Binding Sites on Presenilin*
暂无分享,去创建一个
K. Bales | Christopher W. am Ende | Martin Pettersson | Douglas S. Johnson | Yue-Ming Li | Christina J. Crump | Kwangwook Ahn | N. Pozdnyakov | T. E. Ballard | H. Murrey | T. Ballard
[1] Feng Wang,et al. BMS-708,163 targets presenilin and lacks notch-sparing activity. , 2012, Biochemistry.
[2] K. Bales,et al. Pharmacological Assessment of γ-Secretase Activity from Rodent and Human Brain , 2012 .
[3] K. Bales,et al. Development of clickable active site-directed photoaffinity probes for γ-secretase. , 2012, Bioorganic & medicinal chemistry letters.
[4] B. de Strooper,et al. The mechanism of γ-Secretase dysfunction in familial Alzheimer disease , 2012, The EMBO journal.
[5] D. Scheinberg,et al. Familial Alzheimer Disease Presenilin-1 Mutations Alter the Active Site Conformation of γ-secretase* , 2012, The Journal of Biological Chemistry.
[6] A. Sabirsh,et al. First and Second Generation γ-Secretase Modulators (GSMs) Modulate Amyloid-β (Aβ) Peptide Production through Different Mechanisms , 2012, The Journal of Biological Chemistry.
[7] Y. Shitaka,et al. Differential Effects between γ-Secretase Inhibitors and Modulators on Cognitive Function in Amyloid Precursor Protein-Transgenic and Nontransgenic Mice , 2012, The Journal of Neuroscience.
[8] S. Weggen,et al. Presenilin Is the Molecular Target of Acidic γ-Secretase Modulators in Living Cells , 2012, PloS one.
[9] T. Iwatsubo,et al. Phenylpiperidine‐type γ‐secretase modulators target the transmembrane domain 1 of presenilin 1 , 2011, The EMBO journal.
[10] J. B. Jordan,et al. NSAID-based γ-secretase modulators do not bind to the amyloid-β polypeptide. , 2011, Biochemistry.
[11] K. Bales,et al. Piperidine acetic acid based γ-secretase modulators directly bind to Presenilin-1. , 2011, ACS chemical neuroscience.
[12] Shao Q Yao,et al. Proteome profiling reveals potential cellular targets of staurosporine using a clickable cell-permeable probe. , 2011, Chemical communications.
[13] C. Haass,et al. Novel γ-Secretase Enzyme Modulators Directly Target Presenilin Protein* , 2011, The Journal of Biological Chemistry.
[14] B. Strooper,et al. The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics , 2011, Nature Reviews Drug Discovery.
[15] S. Weggen,et al. Substrate Sequence Influences γ-Secretase Modulator Activity, Role of the Transmembrane Domain of the Amyloid Precursor Protein* , 2011, The Journal of Biological Chemistry.
[16] S. Sieber,et al. Unraveling the protein targets of vancomycin in living S. aureus and E. faecalis cells. , 2011, Journal of the American Chemical Society.
[17] N. Ramsden,et al. Chronic treatment with a novel γ‐secretase modulator, JNJ‐40418677, inhibits amyloid plaque formation in a mouse model of Alzheimer's disease , 2011, British journal of pharmacology.
[18] J. Richardson,et al. Dynamics of Aβ42 Reduction in Plasma, CSF and Brain of Rats Treated with the γ-Secretase Modulator, GSM-10h , 2011, Neurodegenerative Diseases.
[19] Daniel Oehlrich,et al. γ-Secretase modulators as potential disease modifying anti-Alzheimer's drugs. , 2011, Journal of medicinal chemistry.
[20] Gregory W. Kauffman,et al. Novel γ-secretase modulators: a review of patents from 2008 to 2010 , 2011, Expert opinion on therapeutic patents.
[21] G. Multhaup,et al. The amyloid precursor protein C-terminal fragment C100 occurs in monomeric and dimeric stable conformations and binds γ-secretase modulators. , 2011, Biochemistry.
[22] B. Hyman,et al. Substrate docking to γ-secretase allows access of γ-secretase modulators to an allosteric site , 2010, Nature communications.
[23] Xulun Zhang,et al. Activation and intrinsic γ-secretase activity of presenilin 1 , 2010, Proceedings of the National Academy of Sciences.
[24] Xulun Zhang,et al. Modulation of γ-Secretase Reduces β-Amyloid Deposition in a Transgenic Mouse Model of Alzheimer's Disease , 2010, Neuron.
[25] Petra Schneider,et al. Exploring the chemical space of gamma-secretase modulators. , 2010, Trends in pharmacological sciences.
[26] J. Macor,et al. Discovery and Evaluation of BMS-708163, a Potent, Selective and Orally Bioavailable γ-Secretase Inhibitor. , 2010, ACS medicinal chemistry letters.
[27] B. Strooper,et al. The secretases: enzymes with therapeutic potential in Alzheimer disease , 2010, Nature Reviews Neurology.
[28] R. Martone,et al. Recent advances in the identification of gamma-secretase inhibitors to clinically test the Abeta oligomer hypothesis of Alzheimer's disease. , 2009, Journal of medicinal chemistry.
[29] M. Best,et al. Click chemistry and bioorthogonal reactions: unprecedented selectivity in the labeling of biological molecules. , 2009, Biochemistry.
[30] Raphael Kopan,et al. The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism , 2009, Cell.
[31] Kristin E. D. Coan,et al. Promiscuous Aggregate-Based Inhibitors Promote Enzyme Unfolding , 2009, Journal of medicinal chemistry.
[32] E. Koo,et al. Amyloid Precursor Protein Trafficking, Processing, and Function* , 2008, Journal of Biological Chemistry.
[33] M. Wolfe,et al. Substrate-targeting γ-secretase modulators , 2008, Nature.
[34] B. Cravatt,et al. Optimization of activity-based probes for proteomic profiling of histone deacetylase complexes. , 2008, Journal of the American Chemical Society.
[35] Richard M. Page,et al. Generation of Aβ38 and Aβ42 Is Independently and Differentially Affected by Familial Alzheimer Disease-associated Presenilin Mutations and γ-Secretase Modulation* , 2008, Journal of Biological Chemistry.
[36] J. Taunton,et al. Photo-leucine incorporation reveals the target of a cyclodepsipeptide inhibitor of cotranslational translocation. , 2007, Journal of the American Chemical Society.
[37] P. Mehta,et al. Humoral immune responses to peptides derived from the β-amyloid peptide C-terminal sequence , 2007, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[38] M. Wolfe,et al. The initial substrate-binding site of γ-secretase is located on presenilin near the active site , 2005 .
[39] Anna E Speers,et al. Profiling enzyme activities in vivo using click chemistry methods. , 2004, Chemistry & biology.
[40] Chunjiang Yu,et al. Regulated hyperaccumulation of presenilin-1 and the "gamma-secretase" complex. Evidence for differential intramembranous processing of transmembrane subatrates. , 2003, The Journal of biological chemistry.
[41] B. Shoichet,et al. A specific mechanism of nonspecific inhibition. , 2003, Journal of medicinal chemistry.
[42] S. Weggen,et al. Aβ42-lowering Nonsteroidal Anti-inflammatory Drugs Preserve Intramembrane Cleavage of the Amyloid Precursor Protein (APP) and ErbB-4 Receptor and Signaling through the APP Intracellular Domain* , 2003, Journal of Biological Chemistry.
[43] Pritam Das,et al. NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ42 in vivo , 2003 .
[44] T. Iwatsubo,et al. Sulindac Sulfide Is a Noncompetitive γ-Secretase Inhibitor That Preferentially Reduces Aβ42 Generation* , 2003, The Journal of Biological Chemistry.
[45] Rong Wang,et al. A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity , 2001, Nature.
[46] Graeme Irvine Stevenson,et al. L-685,458, an Aspartyl Protease Transition State Mimic, Is a Potent Inhibitor of Amyloid β-Protein Precursor γ-Secretase Activity , 2000 .
[47] Min Xu,et al. Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin 1 , 2000, Nature.
[48] Min Xu,et al. Presenilin 1 is linked with gamma-secretase activity in the detergent solubilized state. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[49] Min Xu,et al. Presenilin 1 is linked with γ-secretase activity in the detergent solubilized state , 2000, Neurobiology of Aging.
[50] B. de Strooper,et al. Presenilins and γ-secretase: structure, function, and role in Alzheimer Disease. , 2012, Cold Spring Harbor perspectives in medicine.
[51] D. Kovacs,et al. The many substrates of presenilin/γ-secretase. , 2011, Journal of Alzheimer's disease : JAD.
[52] K. Blennow,et al. Acute effect on the Aβ isoform pattern in CSF in response to γ-secretase modulator and inhibitor treatment in dogs. , 2010, Journal of Alzheimer's disease : JAD.
[53] J. Hardy,et al. The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .